ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc (FULC)

2,97
-0,17
(-5,41%)
Geschlossen 10 März 9:00PM
2,97
0,00
( 0,00% )
Vor Marktöffnung: 12:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2,97
Gebot
2,88
Fragen
3,64
Volumen
-
0,00 Tagesbereich 0,00
2,86 52-Wochen-Bereich 12,40
Marktkapitalisierung
Handelsende
2,97
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
654.575
Ausgegebene Aktien
53.979.306
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,65
Gewinn pro Aktie (EPS)
-1,8
Erlöse
2,81M
Nettogewinn
-97,34M

Über Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treat... Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Fulcrum Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FULC. The last closing price for Fulcrum Therapeutics was US$2,97. Over the last year, Fulcrum Therapeutics shares have traded in a share price range of US$ 2,86 to US$ 12,40.

Fulcrum Therapeutics currently has 53.979.306 shares in issue. The market capitalisation of Fulcrum Therapeutics is US$160,32 million. Fulcrum Therapeutics has a price to earnings ratio (PE ratio) of -1.65.

FULC Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1399-4.498536930453.10993.412.93290273.17700922CS
4-0.59-16.57303370793.563.942.93997413.48602697CS
12-1.53-344.55.17132.96545754.18070357CS
26-5.4-64.51612903238.378.872.8611933933.68408987CS
52-8-72.926162260710.9712.42.869580505.38258438CS
156-13.28-81.723076923116.2524.792.259302436.1954934CS
260-9.91-76.940993788812.8833.09752.2580572410.04282342CS

FULC - Frequently Asked Questions (FAQ)

What is the current Fulcrum Therapeutics share price?
The current share price of Fulcrum Therapeutics is US$ 2,97
How many Fulcrum Therapeutics shares are in issue?
Fulcrum Therapeutics has 53.979.306 shares in issue
What is the market cap of Fulcrum Therapeutics?
The market capitalisation of Fulcrum Therapeutics is USD 160,32M
What is the 1 year trading range for Fulcrum Therapeutics share price?
Fulcrum Therapeutics has traded in the range of US$ 2,86 to US$ 12,40 during the past year
What is the PE ratio of Fulcrum Therapeutics?
The price to earnings ratio of Fulcrum Therapeutics is -1,65
What is the cash to sales ratio of Fulcrum Therapeutics?
The cash to sales ratio of Fulcrum Therapeutics is 57,12
What is the reporting currency for Fulcrum Therapeutics?
Fulcrum Therapeutics reports financial results in USD
What is the latest annual turnover for Fulcrum Therapeutics?
The latest annual turnover of Fulcrum Therapeutics is USD 2,81M
What is the latest annual profit for Fulcrum Therapeutics?
The latest annual profit of Fulcrum Therapeutics is USD -97,34M
What is the registered address of Fulcrum Therapeutics?
The registered address for Fulcrum Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Fulcrum Therapeutics website address?
The website address for Fulcrum Therapeutics is www.fulcrumtx.com
Which industry sector does Fulcrum Therapeutics operate in?
Fulcrum Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AWHAspira Womans Health Inc
US$ 0,40
(102,02%)
69,42M
TSVT2seventy bio Inc
US$ 4,93
(76,07%)
489,61k
SNOASonoma Pharmaceuticals Inc
US$ 4,30
(54,12%)
11,28M
TNONTenon Medical Inc
US$ 1,91
(52,80%)
10,58M
ADTNADTRAN Holdings Inc
US$ 11,49
(35,34%)
91
MBXMBX Biosciences Inc
US$ 5,01
(-44,21%)
2
JANXJanux Therapeutics Inc
US$ 20,05
(-33,65%)
40
ARVNArvinas Inc
US$ 13,15
(-25,11%)
44,48k
SVRASavara Inc
US$ 2,01
(-24,44%)
4
SNCRSynchronoss Technologies Inc
US$ 6,01
(-22,45%)
4
AWHAspira Womans Health Inc
US$ 0,40
(102,02%)
69,42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,58
(2,71%)
20,03M
BTOGBit Origin Ltd
US$ 0,4908
(3,30%)
14,52M
SNOASonoma Pharmaceuticals Inc
US$ 4,30
(54,12%)
11,28M
CUTRCutera Inc
US$ 0,1565
(21,79%)
10,82M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen